Procter & Gamble Health Limited (PGHL.NS)
INR 5467.25
(0.04%)
INR 5467.25
(0.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.78 Billion INR | -33.38% |
| 2022 | 8.67 Billion INR | 19.71% |
| 2021 | 7.24 Billion INR | 11.27% |
| 2020 | 6.51 Billion INR | 62.17% |
| 2019 | 4.01 Billion INR | -30.45% |
| 2018 | 5.77 Billion INR | -12.27% |
| 2017 | 6.58 Billion INR | 14.33% |
| 2016 | 5.75 Billion INR | 18.68% |
| 2015 | 4.85 Billion INR | 8.71% |
| 2014 | 4.46 Billion INR | 7.98% |
| 2013 | 4.13 Billion INR | 16.64% |
| 2012 | 3.54 Billion INR | 12.59% |
| 2011 | 3.14 Billion INR | 4.51% |
| 2010 | 3.01 Billion INR | 12.8% |
| 2009 | 2.67 Billion INR | 16.36% |
| 2008 | 2.29 Billion INR | 21.84% |
| 2007 | 1.88 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.73 Billion INR | 16.42% |
| 2023 Q3 | 1.25 Billion INR | -18.89% |
| 2023 FY | 5.78 Billion INR | -33.38% |
| 2023 Q2 | 1.55 Billion INR | -28.72% |
| 2023 Q1 | 2.17 Billion INR | 5.06% |
| 2023 Q4 | 1.48 Billion INR | 18.27% |
| 2022 Q1 | 2.11 Billion INR | 31.83% |
| 2022 Q2 | 2.28 Billion INR | 8.29% |
| 2022 Q3 | 2.2 Billion INR | -3.36% |
| 2022 Q4 | 2.07 Billion INR | -6.14% |
| 2022 FY | 8.67 Billion INR | 19.71% |
| 2021 Q1 | 1.9 Billion INR | 23.95% |
| 2021 Q3 | 1.87 Billion INR | -0.3% |
| 2021 Q4 | 1.6 Billion INR | -14.39% |
| 2021 Q2 | 1.87 Billion INR | -1.42% |
| 2021 FY | 7.24 Billion INR | 11.27% |
| 2020 Q3 | 1.52 Billion INR | -13.74% |
| 2020 Q2 | 1.76 Billion INR | 4.51% |
| 2020 FY | 6.51 Billion INR | 62.17% |
| 2020 Q1 | 1.69 Billion INR | 12.85% |
| 2020 Q4 | 1.53 Billion INR | 0.74% |
| 2019 Q4 | 1.49 Billion INR | 1.25% |
| 2019 FY | 4.01 Billion INR | -30.45% |
| 2019 Q3 | 1.47 Billion INR | -5.51% |
| 2019 Q2 | 1.56 Billion INR | 6.34% |
| 2019 Q1 | 1.47 Billion INR | -14.44% |
| 2018 Q4 | 1.72 Billion INR | 14.02% |
| 2018 Q2 | 1.37 Billion INR | -11.44% |
| 2018 Q1 | 1.55 Billion INR | 2.89% |
| 2018 FY | 5.77 Billion INR | -12.27% |
| 2018 Q3 | 1.5 Billion INR | 9.43% |
| 2017 Q3 | 1.84 Billion INR | -2.14% |
| 2017 FY | 6.58 Billion INR | 14.33% |
| 2017 Q4 | 1.51 Billion INR | -18.03% |
| 2017 Q2 | 1.88 Billion INR | 3.13% |
| 2017 Q1 | 1.82 Billion INR | 19.86% |
| 2016 Q3 | 1.37 Billion INR | -8.73% |
| 2016 Q4 | 1.52 Billion INR | 10.82% |
| 2016 FY | 5.75 Billion INR | 18.68% |
| 2016 Q1 | 1.48 Billion INR | 11.81% |
| 2016 Q2 | 1.5 Billion INR | 1.47% |
| 2015 Q2 | 1.23 Billion INR | -1.95% |
| 2015 FY | 4.85 Billion INR | 8.71% |
| 2015 Q4 | 1.32 Billion INR | 8.0% |
| 2015 Q3 | 1.23 Billion INR | -0.05% |
| 2015 Q1 | 1.25 Billion INR | 4.35% |
| 2014 Q4 | 1.2 Billion INR | 15.99% |
| 2014 FY | 4.46 Billion INR | 7.98% |
| 2014 Q1 | 1.17 Billion INR | 2.5% |
| 2014 Q2 | 1.12 Billion INR | -4.05% |
| 2014 Q3 | 1.03 Billion INR | -8.04% |
| 2013 Q4 | 1.14 Billion INR | 13.54% |
| 2013 FY | 4.13 Billion INR | 16.64% |
| 2013 Q2 | 984.48 Million INR | -8.27% |
| 2013 Q1 | 1.07 Billion INR | -2.96% |
| 2013 Q3 | 1.01 Billion INR | 2.69% |
| 2012 Q4 | 1.1 Billion INR | 13.97% |
| 2012 Q3 | 970.41 Million INR | 16.07% |
| 2012 FY | 3.54 Billion INR | 12.59% |
| 2012 Q2 | 836.06 Million INR | -15.33% |
| 2012 Q1 | 987.39 Million INR | 2.66% |
| 2011 Q4 | 961.8 Million INR | 26.71% |
| 2011 Q1 | 906.52 Million INR | 0.0% |
| 2011 Q2 | 656.63 Million INR | -27.57% |
| 2011 Q3 | 759.03 Million INR | 15.59% |
| 2011 FY | 3.14 Billion INR | 4.51% |
| 2010 FY | 3.01 Billion INR | 12.8% |
| 2009 FY | 2.67 Billion INR | 16.36% |
| 2008 FY | 2.29 Billion INR | 21.84% |
| 2007 FY | 1.88 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -188.74% |
| Ind-Swift Limited | 2.17 Billion INR | -166.114% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -292.81% |
| Sakar Healthcare Limited | 699.58 Million INR | -726.404% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 94.722% |
| Innova Captab Limited | 3.46 Billion INR | -66.878% |
| Divi's Laboratories Limited | 32.44 Billion INR | 82.178% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 7.092% |
| Morepen Laboratories Limited | 6.16 Billion INR | 6.166% |
| Mankind Pharma Limited | 42.19 Billion INR | 86.299% |
| Sequent Scientific Limited | 2.97 Billion INR | -94.089% |
| Wanbury Limited | 1.73 Billion INR | -234.061% |
| Laurus Labs Limited | 15.44 Billion INR | 62.577% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -19.864% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 53.5% |
| Alembic Limited | 1 Billion INR | -478.078% |
| Hikal Limited | 5.95 Billion INR | 2.964% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 78.412% |
| Neuland Laboratories Limited | 8.24 Billion INR | 29.904% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 62.111% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 91.662% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -22.511% |
| Themis Medicare Limited | 2.42 Billion INR | -138.9% |
| RPG Life Sciences Limited | 2.48 Billion INR | -132.839% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 95.383% |
| Lupin Limited | 125.09 Billion INR | 95.378% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -176.089% |
| Wockhardt Limited | 7.72 Billion INR | 25.111% |
| Vaishali Pharma Limited | 90.32 Million INR | -6300.806% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 0.857% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -785.916% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 70.568% |
| FDC Limited | 6.58 Billion INR | 12.22% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 96.466% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -831.767% |
| Eris Lifesciences Limited | 10.42 Billion INR | 44.552% |
| Venus Remedies Limited | 2.18 Billion INR | -164.888% |
| ZIM Laboratories Limited | 1.26 Billion INR | -356.014% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -56.447% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -992.611% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 37.203% |
| Shilpa Medicare Limited | 3.56 Billion INR | -62.312% |
| Albert David Limited | 1.4 Billion INR | -310.585% |
| Ajanta Pharma Limited | 21.06 Billion INR | 72.553% |
| Hester Biosciences Limited | 1.27 Billion INR | -353.924% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -40.214% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 449.139% |
| Gufic Biosciences Limited | 4.07 Billion INR | -41.919% |
| Windlas Biotech Limited | 1.33 Billion INR | -331.834% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -5014.97% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -736.438% |
| Granules India Limited | 16.79 Billion INR | 65.585% |
| Aarti Drugs Limited | 8.31 Billion INR | 30.48% |
| Bal Pharma Limited | 770.19 Million INR | -650.641% |
| Alkem Laboratories Limited | 52.29 Billion INR | 88.945% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 97.763% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -206.402% |
| Medicamen Biotech Limited | 495.49 Million INR | -1066.793% |
| Unichem Laboratories Limited | 4.86 Billion INR | -18.838% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -1178.638% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -45985.293% |
| Valiant Laboratories Limited | 138.02 Million INR | -4088.54% |
| Orchid Pharma Limited | 2.32 Billion INR | -149.166% |
| Medico Remedies Limited | 262.14 Million INR | -2105.429% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -39.877% |
| Ipca Laboratories Limited | 48.58 Billion INR | 88.1% |
| Brooks Laboratories Limited | 65.62 Million INR | -8710.424% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -933.31% |
| Piramal Enterprises Limited | 8.04 Billion INR | 28.122% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 87.635% |
| NATCO Pharma Limited | 25.73 Billion INR | 77.536% |
| Suven Life Sciences Limited | -200.79 Million INR | 2979.226% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 5416.377% |
| Strides Pharma Science Limited | 14.38 Billion INR | 59.818% |
| Indoco Remedies Limited | 8.04 Billion INR | 28.119% |
| Alpa Laboratories Limited | 188.89 Million INR | -2960.642% |
| Lasa Supergenerics Limited | 121.02 Million INR | -4676.832% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -1378.369% |